The Journal of Allergy and Clinical Immunology
Volume 126, Issue 1 , Pages 52-58.e5 , July 2010

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study

  • John M. Brehm, MD, MPH

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Division of Pulmonary/Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Department of Medicine, Harvard Medical School, Boston, Mass
    • ,
  • Brooke Schuemann, BS

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • ,
  • Anne L. Fuhlbrigge, MD

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Division of Pulmonary/Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • ,
  • Bruce W. Hollis, PhD

      Affiliations

    • Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC
    • ,
  • Robert C. Strunk, MD

      Affiliations

    • Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo
    • ,
  • Robert S. Zeiger, MD, PhD

      Affiliations

    • Department of Allergy, Kaiser Permanente Medical Center, San Diego, Calif
    • ,
  • Scott T. Weiss, MD, MS

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Division of Pulmonary/Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Center for Genomic Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Department of Medicine, Harvard Medical School, Boston, Mass
    • These authors contributed equally to this work.
    • ,
  • Augusto A. Litonjua, MD, MPH

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Division of Pulmonary/Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
    • Department of Medicine, Harvard Medical School, Boston, Mass
    • Corresponding Author InformationReprint requests: Augusto A. Litonjua, MD, MPH, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115.
    • These authors contributed equally to this work.
    • ,
  • Childhood Asthma Management Program Research Group

      Affiliations

    • Members of the Childhood Asthma Management Program Research Group are detailed in this article's Online Repository at www.jacionline.org.

Received 22 October 2009 ,Revised 27 March 2010 ,Accepted 30 March 2010.

References 

  1. CDC National Center for Health Statistics. Asthma prevalence, health care use and mortality: United States, 2003-05. http://www.cdc.gov/nchs/data/hestat/asthma03-05/asthma03-05.htm.
  2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–478
  3. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2007;(165):1–209
  4. American Lung Association. Asthma. American Lung Association Lung Disease Data. New York: American Lung Association; 2008;
  5. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009;39:193–202
  6. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181:7090
  7. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184:965–974
  8. Litonjua AA. Childhood asthma may be a consequence of vitamin D deficiency. Curr Opin Allergy Clin Immunol. 2009;9:202–207
  9. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179:765–771
  10. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. Control Clin Trials. 1999;20:91–120
  11. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054–1063
  12. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317–322
  13. Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med. 2005;352:515–516
  14. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem. 1993;39:529–533
  15. Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem. 1985;31:1815–1819
  16. Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, et al. The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer. 2010;62:51–57
  17. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28
  18. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  19. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85:649–650
  20. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–178
  21. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773
  22. Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, et al. Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4:e5810
  23. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116:146–155
  24. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204–210
  25. Brunekreef B, Noy D, Clausing P. Variability of exposure measurements in environmental epidemiology. Am J Epidemiol. 1987;125:892–898
  26. Hilgenfeld MS, Simon S, Blowey D, Richmond W, Alon US. Lack of seasonal variations in urinary calcium/creatinine ratio in school-age children. Pediatr Nephrol. 2004;19:1153–1155
  27. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics. 2009;123:797
  28. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169:626–632
  29. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D(3) and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol. 2007;103:631–634
  30. Taback SP, Simons FE. Anaphylaxis and vitamin D: a role for the sunshine hormone?. J Allergy Clin Immunol. 2007;120:128–130

 We acknowledge the Childhood Asthma Management Program (CAMP) investigators and research team, supported by the National Heart, Lung, and Blood Institute, for collection of CAMP Genetics Ancillary Study data. All work on data collected from the CAMP Genetics Ancillary Study was conducted at the Channing Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, and T32 HL07427 from the National Heart, Lung, and Blood Institute(NHLBI)/National Institutes of Health. We also acknowledge the Asthma Clinical Research Network (ACRN) investigators and research teams supported by U01 HL51510, U01 HL51834, U01 HL51831, U01 HL51845, U01 HL 51843, M01 RR00079, and M01 RR03186 from the NHLBI. This work was also supported by National Institutes of Health grant R21HL089842.

 Disclosure of potential conflict of interest: A. L. Fuhlbrigge is on an advisory board for and has given talks for Merck and has received continuing medical education from Advanced Health Media, funded through GlaxoSmithKline. B. W. Hollis has consulted for DiaSorin and has received research support from the National Institutes of Health. R. S. Zeiger has consulted for AstraZeneca, Aerocrine, Genentech, Novartis, Merck, Schering-Plough, and MedImmune and has received indirect research support from Aerocrine, Genentech, GlaxoSmithKline, Merck, AstraZeneca, and TEVA Pharmaceuticals. A. A. Litonjua has received research support from the National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(10)00657-3

doi: 10.1016/j.jaci.2010.03.043

The Journal of Allergy and Clinical Immunology
Volume 126, Issue 1 , Pages 52-58.e5 , July 2010

Article Tools

* Image Usage & Resolution